Pfizer buying Hospira for about $15.23 billion

Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its established global pharmaceutical business. The buyout will also help Pfizer tap into the growing market for biosimilars, which are cheaper versions of biologic drugs that are...

Death rate 32% higher than average

Deaths among people aged over 65 have been higher than expected for six weeks, even taking the time of year into account The death rate in England and Wales is around a third higher than normal for this time of year, official figures show. Some 28,800 deaths were...